Lumida
/AMGN
⌘K
Amgen Inc

Amgen Inc

AMGN
$377.35USD-1.34%-5.12 today

MARKET CAP

204.0B

P/E (TTM)

26.2x

FWD P/E

DAY RANGE

$377 – $387

52W RANGE

$270
$447

AI Summary

Stalk
Sell NowMedium

After violating horizontal support with momentum and volume confirming downside, AMGN’s medium-term bias is bearish. The active Support Failure pattern signals further potential declines as broken support may now serve as resistance. Short-term conditions, with price below declining 9, 20, and 50 EMAs and deep oversold RSI, favor selling now. Long-term uptrend remains intact above the 200-day SMA, but near-term distribution calls for immediate execution to capture continuation of the downtrend.

  • Q2 2026 revenue $10.1B (+10% YoY) and EPS $6.29 topped estimates.
  • Full-year 2026 revenue guidance raised to $38.2–$39.4B on product strength.
  • Shares trade ~8% above $360 fair value estimate, risking correction.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$26.0B$26.3B$28.2B$33.4B$36.8B
YoY %+2.2%+1.3%+7.1%+18.6%+10.0%
P / Sales5.0x5.4x5.7x4.2x4.8x
EV / Sales6.8x7.4x8.5x6.4x6.8x
Gross Profit, Adj.$19.5B$19.9B$19.7B$20.6B$24.7B
YoY %+1.3%+2.0%-0.9%+4.2%+20.2%
Margin %75.2%75.7%70.0%61.5%67.2%
EV / Gross Profit9.0x9.8x12.2x10.5x10.1x
EBITDA, Adj.$12.5B$13.0B$12.0B$12.8B$14.2B
YoY %-1.6%+3.5%-7.8%+7.4%+10.9%
Margin %48.3%49.3%42.5%38.4%38.8%
EV / EBITDA14.0x15.0x20.1x16.7x17.6x
EBIT$7.6B$9.6B$7.9B$7.3B$9.1B
YoY %-16.4%+25.2%-17.4%-8.1%+25.1%
Margin %29.4%36.3%28.0%21.7%24.7%
EV / EBIT23.0x20.4x30.4x29.6x27.6x
Net Income$5.9B$6.6B$6.7B$4.1B$7.7B
YoY %-18.9%+11.2%+2.5%-39.1%+88.5%
Net Margin22.7%24.9%23.8%12.2%21.0%
EPS (GAAP)$10.28$12.11$12.49$7.56$14.23
YoY %-16.5%+17.8%+3.1%-39.5%+88.2%